JPRN-UMIN000012060尚未招募未知
Effects of azilsartan for coagulatic and fiblinolytic markers in pathients with hypertension - azilsartan and coagulatic and fiblinolytic markers
Shosaku Nomura0 个研究点目标入组 100 人开始时间: 2013年10月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Effects of azilsartan compared to other angiotensin receptor blockers on left ventricular hypertrophy and the sympathetic nervous system in hemodialysis patientsHypertensionJPRN-UMIN000011845Department of Cardiology, Tsukazaki Hospital17
已完成
不适用
Ehime Study - Effect of Azilsartan on Home Blood Pressureessential hypertensionJPRN-UMIN000011936Department of Cardiology, Pulmonology, Hypertension & Nephrology200
未知
Unknown
A study to explore the effects of Azilsartan compared to Telmisartan on insulin resistance of patients with essential hypertension on type 2 diabetes mellitus by HOMA-R (AT-HOMA)Essential hypertension complicated by type 2 diabetes mellitusJPRN-jRCT1080222411TAKEDA PHARMACEUTICAL COMPANY LTD.40
未知
Unknown
ALIVE studyEssential hypertensive patients with stable angina and dyslipidemiaJPRN-jRCT1080222782TAKEDA PHARMACEUTICAL COMPANY LTD.51
已完成
不适用
clinical outcomes of Azilsartan, angiotensin receptor blocker on castration-resistant prostate cancercastration-resistant prostate cancerJPRN-UMIN000012656Shinshu University School of Medicine20